Reanalysis of the anthrax epidemic in Rhodesia, 1978-1984

PeerJ
James M WilsonJulie Smith-Gagen

Abstract

In the mid-1980s, the largest epidemic of anthrax of the last 200 years was documented in a little known series of studies by Davies in The Central African Journal of Medicine. This epidemic involved thousands of cattle and 10,738 human cases with 200 fatalities in Rhodesia during the Counterinsurgency. Grossly unusual epidemiological features were noted that, to this day, have not been definitively explained. This study performed a historical reanalysis of the data to reveal an estimated geographic involvement of 245,750 km(2), with 171,990 cattle and 17,199 human cases. Here we present the first documented geotemporal visualization of the human anthrax epidemic.

References

Jul 28, 2019·Reproduction in Domestic Animals = Zuchthygiene·Mari FrimanMagnus Andersson

Citations

Mar 1, 1983·Annals of Tropical Paediatrics·A S Latif, K J Nathoo
Jul 26, 1980·The Veterinary Record·J A LawrenceR A Norval
Nov 18, 1994·Science·M MeselsonO Yampolskaya
Sep 16, 1998·American Journal of Public Health·M KulldorffC R Key
Oct 25, 2002·Emerging Infectious Diseases·David M Morens
Jan 30, 2007·The Veterinary Record·S B CleggP M Lindeque
Jun 28, 2011·Tropical Animal Health and Production·Silvester Maravanyika ChikeremaE Bhebhe

Related Concepts

Study
Anthrax Vaccines
Anthrax Disease
Documented
Bacillus anthracis
Epidemiology
Anthrax
Cattle
Tissue Therapy, Historical

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Journal des praticiens; revue générale de clinique et de thérapeutique
The British Journal of Clinical Practice
A J GRAHAM
© 2020 Meta ULC. All rights reserved